A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response.

Pharmaceutics · 2022 · PMC9413348 · PMID 36015223

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

highly significantno p-value reported

Differences were classified as follows: (1) non-significant (labeled as ns), when a p value is >0.05, (2) significant (labeled as *), when a p value is <0.05, (3) highly significant (labeled as **), when a p value is <0.01, and (4) extremely significant, when a p value is <0.001 (labeled as ***), or <0.0001 (labeled as ****). 3.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.